Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.
Also called NCT01379677
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 135 participants
- Sponsor
- Advanced Accelerator Applications
- Registry
-
NCT01379677 -
2009-016645-25
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01379677. Non-randomized; no masking; primary purpose diagnostic. Start 2011-02 (registry gives no type); primary completion 2013-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Rubidium-82
- Intervention (Drug)
- Sestamibi. reconstitution with sodium pertechnetate (99mTc)
- Lead sponsor
- Advanced Accelerator Applications
Record details
- Record id
cardio:ct-nct01379677- Content hash
c44d8a97721feda5e3f1bc8e76f95b8ed99ff8b347b9910c473c36b7fd565f5c